PROTOCOL NRG-CC017
ACTIVATION
NRG-CC017: "A randomized phase III study comparing temporally-modulated pulsed radiation therapy (TMPRT) versus standard radiation therapy with temozolomide for adults with newly diagnosed MGMT-unmethylated glioblastoma"
Activation Date: April 1, 2026
Documents are posted on the CTSU website.
|